Kyanos Biotechnology is a Saudi-based algal biotechnology company dedicated to mariculture and the use of waste carbon dioxide streams as feedstock. We are interested in the application of Red Sea algal biomass as a resource for high value speciality chemicals for cosmetic and pharmaceutical applications.
Kyanos Biotechnology was built upon 5 years of genomics-led microbiological research and industrial culture development by KAUST and SABIC funded academic and industrial partners. We have developed a pipeline of micro-algae strains now ready for commercial and industrial enterprises to be a disruptive technology in this field. Our bio-portfolio of growth-optimised, superior micro-algal strains that are ready for year-round outdoor culturing and production. The benefit to Saudi Arabia is the exploitation of a natural, bio-renewable resource and a step away from the dependence on chemicals derived from petroleum distillates.